You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.


Go back

About the Ellipta device

The Ellipta is a multi-dose dry powder inhaler (DPI). Two different medicines for asthma and/or COPD are available using the Ellipta device. The inhaler is packaged within a moisture-protective foil tray with a desiccant and a peelable lid.

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at
By reporting side effects you can help provide more information on the safety of this medicine.

Ellipta is a registered trademark of the GlaxoSmithKline group of companies.